ClinicalTrials.Veeva

Menu

Microlyte Dressing in the Management of Wounds

M

Mission Health System, Asheville, NC

Status

Unknown

Conditions

Wound Heal

Treatments

Device: Wound Healing

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03204851
16-08-1608

Details and patient eligibility

About

The purpose of this pilot study is to assess the efficacy of Microlyte Ag wound dressing when used in complex skin wounds. Microlyte Ag is a class-II medical device cleared by the FDA for prescription and over the counter use in humans. Primary clinical end point of study is percentage change in wound size from initiation of Microlyte Ag treatment through 90 days or until wound closure. Patient population comprises patients referred to Mission's Wound Healing and Hyperbaric Center for management of their wounds. Targeted enrollment is 100 subjects distributed into 4 study cohorts corresponding to the type of wound treated: venous stasis ulcer (20 patients); diabetic foot ulcer [DFU] (20 patients); pressure ulcer (20 patients); wounds of various other etiologies (40 patients).

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women ≥18 years of age, inclusive
  • Venous stasis ulcer, DFU, pressure ulcer, or other wound sufficiently complex as to be referred to Clinical Investigators at Mission's Wound Care and Bariatric Center
  • Patient must be competent to consent for self

Exclusion criteria

  • Patients younger than 18 years of age
  • Women who are pregnant or nursing
  • Prisoners

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 4 patient groups

Venous Stasis Ulcer
Active Comparator group
Description:
Venous Stasis Ulcer
Treatment:
Device: Wound Healing
Pressure Ulcers
Active Comparator group
Description:
Pressure Ulcers
Treatment:
Device: Wound Healing
Diabetic Foot Ulcers
Active Comparator group
Description:
Diabetic Foot Ulcers
Treatment:
Device: Wound Healing
Wounds from a variety of etiologies
Active Comparator group
Description:
Wounds from a variety of etiologies
Treatment:
Device: Wound Healing

Trial contacts and locations

1

Loading...

Central trial contact

Lorinda Baker; Ashley Boone, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems